Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Francesca Crasto"'
Autor:
Filomena Daraio, Francesca Crasto, Yulia Volchek, Arnon Nagler, Ninette Amariglio, Roberta Lorenzatti, Giuseppe Saglio, Maya Koren-Michowitz, Enrico Gottardi, Avichai Shimoni
Publikováno v:
Biology of Blood and Marrow Transplantation. 21:1852-1855
Real-time quantitative PCR (RT-qPCR) is commonly used for follow-up of chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors, but its current sensitivity does not allow detection of very low BCR-ABL levels. Therefore RT-qPCR
Autor:
Francesca Crasto, Enrico Gottardi, Giuseppe Saglio, Alessandro Morotti, Sabrina Crivellaro, Riccardo Taulli, Ubaldo Familiari, Rocco Piazza, Mauro Papotti, Giovanna Carrà, Sara Redaelli, Angelo Guerrasio, Cristina Panuzzo, Davide Torti, Alessandro Volpengo
Publikováno v:
Oncotarget
Tumor suppressor function can be modulated by subtle variation of expression levels, proper cellular compartmentalization and post-translational modifications, such as phosphorylation, acetylation and sumoylation. The non-genomic loss of function of
Autor:
Enrico Gottardi, Santa Errichiello, Fausto Castagnetti, Maria Teresa Bochicchio, Fabrizio Pane, Francesca Crasto, Barbara Izzo, Giovanni Martinelli, Claudia Venturi, Giovanna Rege-Cambrin, Carmen Fava, Filomena Daraio, Giuseppe Saglio, Roberta Lorenzatti
Molecular tests are the best way to monitor CML course in patients under treatment with tyrosine kinase inhibitors (TKI). International guidelines indicate the absolute copy number of the control gene ABL1 as reference for the definition of the sensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0088fcf9f9570a5db6c3a1da34123cfa
http://hdl.handle.net/2318/1796645
http://hdl.handle.net/2318/1796645
Publikováno v:
British journal of haematology
176 (2017): 491–495.
info:cnr-pdr/source/autori:Augusta Di Savino Valentina Gaidano Antonietta Palmieri Francesca Crasto Alessandro Volpengo Roberta Lorenzatti Patrizia Scaravaglio Alessandro Manello Paolo Nicoli Enrico Gottardi Giuseppe Saglio Daniela Cilloni Marco De Gobbi/titolo:Clinical significance ofTFR2andEPORexpression in bone marrow cells in myelodysplastic syndromes/doi:/rivista:British journal of haematology (Print)/anno:2017/pagina_da:491/pagina_a:495/intervallo_pagine:491–495/volume:176
176 (2017): 491–495.
info:cnr-pdr/source/autori:Augusta Di Savino Valentina Gaidano Antonietta Palmieri Francesca Crasto Alessandro Volpengo Roberta Lorenzatti Patrizia Scaravaglio Alessandro Manello Paolo Nicoli Enrico Gottardi Giuseppe Saglio Daniela Cilloni Marco De Gobbi/titolo:Clinical significance ofTFR2andEPORexpression in bone marrow cells in myelodysplastic syndromes/doi:/rivista:British journal of haematology (Print)/anno:2017/pagina_da:491/pagina_a:495/intervallo_pagine:491–495/volume:176
The experiments were conceived, designed and performed by Augusta Di Savino, Antonietta Palmieri, Marco De Gobbi. RNA extraction from patients' bone marrow samples was performed by Alessandro Volpengo, Francesca Crasto, Roberta Lorenzatti and Enrico
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::1860e89601c18b2a774b96c741048a0b
http://www.cnr.it/prodotto/i/368982
http://www.cnr.it/prodotto/i/368982
Autor:
Enrico Gottardi, Carmen Fava, Paola Berchialla, Alessandro Volpengo, Filomena Daraio, Irene Dogliotti, Francesca Crasto, Giovanna Rege-Cambrin, Bruno Di Gioacchino, Roberta Lorenzatti, Cristina Fantino, Giuseppe Saglio
Publikováno v:
Clinical lymphoma, myelomaleukemia.
An early molecular response has a strong predictive value in chronic myeloid leukemia (CML). Recently, the halving time (velocity of early BCR-ABL1 transcript elimination) has been shown to represent an additional prognostic index. Our objective was
Autor:
Paolo Nicoli, Giuseppe Saglio, Francesca Crasto, Roberta Lorenzatti, Valentina Gaidano, Alessandro Volpengo, Alessandro Manello, Antonietta Palmieri, Augusta Di Savino, Patrizia Scaravaglio, Daniela Cilloni, Enrico Gottardi, Marco De Gobbi
Publikováno v:
British journal of haematology. 176(3)
Autor:
Roberta Lorenzatti, Maria Teresa Bochicchio, Filomena Daraio, Caterina De Benedittis, Enrico Gottardi, Emanuela Ottaviani, Francesca Crasto, Giuseppe Saglio, Barbara Izzo, Alessandro Volpengo, Claudia Venturi, Biagio De Angelis, Fabrizio Pane, Giovanni Martinelli
Publikováno v:
Blood. 124:1809-1809
Effective management of tyrosine kinase inhibitor (TKI) therapy for patients with CML requires frequent patient testing to monitor patient disease status. The gold standard for this testing is a PCR measurement of the BCR-ABL/ABL transcript ratio. He
Autor:
Irene Dogliotti, Enrico Gottardi, Giovanna Rege-Cambrin, Paola Berchialla, Giuseppe Saglio, Bruno Di Gioacchino, Filomena Daraio, Carmen Fava, Cristina Fantino, Alessandro Volpengo, Francesca Crasto, Roberta Lorenzatti
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:S33
Autor:
Giovanna Rege-Cambrin, Carmen Fava, Enrico Gottardi, Filomena Daraio, Emilia Giugliano, Francesca Crasto, Roberta Lorenzatti, Alessandro Volpengo, Bruno Di Gioacchino, Giuseppe Saglio
Publikováno v:
Blood. 122:2592-2592
Background Consensus has been achieved that standardized molecular quantitative analysis (RQ-PCR) on peripheral blood (PB) is a suitable method for monitoring residual disease in chronic myeloid leukemia (CML). However, BM is still obtained at specif
Autor:
Avichai Shimoni, Maya Koren-Michowitz, Yulia Volchek, Enrico Gottardi, Ninette Amariglio, Francesca Crasto, Giuseppe Saglio, Arnon Nagler, Roberta Lorenzatti, Filomena Daraio
Publikováno v:
Blood. 120:1690-1690
Abstract 1690 RQ-PCR has become the major method for the follow up of CML pts in the tyrosine kinase inhibitor (TKI) era. In CML pts undergoing allogeneic SCT (Allo-SCT) it has been shown that successive increase in quantitative BCR ABL transcript le